Abeona Therapeutics Inc. Common Stock (ABEO)
Abeona Therapeutics Inc. is a clinical-stage biotech company focused on developing gene and cell therapies for rare genetic diseases. The company aims to address serious and life-threatening conditions by utilizing innovative approaches to improve patient outcomes in areas such as immune disorders, neurological diseases, and genetic disorders.
Company News
The global cancer gene therapy market is projected to grow from $4.52 billion in 2024 to $13.58 billion by 2030, driven by rising cancer incidences, advancements in personalized medicine, and innovative gene therapy technologies like CRISPR and CAR-T solutions.
The Dow Jones index closed higher by around 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Abeona Therapeutics The Trade: Abeona Therapeutics Inc. (NASDAQ: ABEO) Director, Chief Executive Officer Vishwas Seshadri acquired a total of 20,000 shares ...
3 Penny Stocks To Watch Now The post 3 Penny Stocks To Watch Before Next Week; Time To Buy? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Koninklijke Philips (PHG) banks on its new AI solutions to address issues faced by Radiology experts in the healthcare industry and drive prospects.